Accentia Biopharmaceutical requests six-month exclusivity extension to analyze options

By Caroline Salls

Pittsburgh, Feb. 17 - Accentia Biopharmaceuticals, Inc. requested an extension to its exclusive period to file a plan of reorganization and solicit votes on the plan, according to a Monday filing with the U.S. Bankruptcy Court for the Middle District of Florida.

The company wants to extend its exclusive plan-filing period to Sept. 6, 2009 from March 10 and the solicitation period to Nov. 5, 2009.

According to the motion, the company has spent a significant amount of time in its bankruptcy case normalizing and stabilizing its business operations, addressing employee issues and talking with creditors, vendors, suppliers and customers.

Now, Accentia said it needs more time to thoroughly analyze its restructuring options.

Accentia, a biopharmaceutical company based in Tampa, Fla., filed for bankruptcy on Nov. 10. Its Chapter 11 case number is 08-17795.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.